deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 3-arm NCT07140380

Phase 2b Controlled Study

Phase 2b, Proof-of-Concept, Single-center, Double-Masked, Randomized Study Comparing the Safety, Tolerability, and Efficacy of Three Different Ophthalmic Eyelid Wipe Dosing Techniques Using IVW-1001 in Subjects With Dry Eye Disease

Sponsor: IVIEW Therapeutics Inc.

Conditions Dry Eye Disease
Interventions IVW-1001 Ophthalmic Eyelid Wipe
Updated 2 times since 2025 Last updated: Sep 9, 2025 Started: Aug 20, 2025 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07140380, this PHASE2 trial focuses on Dry Eye Disease and remains ongoing. Sponsored by IVIEW Therapeutics Inc., it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshotRecruiting~Oct 2025 – present · 9 months · monthly snapshotActive Not Recruiting

Change History

2 versions recorded

  1. Oct 2025 — Present [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Sep 2025 — Oct 2025 [monthly]

    Recruiting PHASE2

    First recorded

Aug 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • IVIEW Therapeutics Inc.
Data source: IVIEW Therapeutics Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations